TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'

Go back to TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'

Moderna (MRNA) announces U.S. expansion and 2023

March 10, 2023 11:31 AM EST

Moderna, Inc., (NASDAQ: MRNA) announced Friday that the biotechnology company is expanding its U.S. presence. The company plans to establish a corporate presence on the West Coast with new offices in South San Francisco, California and Seattle, Washington. Moderna also plans to hire approximately 2,000 new employees globally by the end of 2023.

Moderna's West Coast presence joins additional U.S. locations in Cambridge, Massachusetts;... More

Moderna (MRNA) plans to hire approximately 2,000 new employees in 2023

March 10, 2023 11:02 AM EST

oderna, Inc., (NASDAQ: MRNA) announced that it is expanding its U.S. presence and establishing a corporate presence on the West Coast with new offices in South San Francisco, California and Seattle, Washington. Moderna's Seattle location will provide technology solutions across the enterprise and Moderna Genomics will expand to South San Francisco. Moderna also plans to hire approximately 2,000 new employees globally by the end of 2023.

Moderna's West Coast presence joins additional U.S. locations in Cambridge, Massachusetts; Norwood, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; and Princeton, New Jersey.

"Our team has... More